Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Janine Murr

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-1079-2545; OpenAlex author ID A5086428901. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 5

  1. The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70794↗
  2. Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis. Co-author DOI 10.1038/s41467-026-73189-8↗
  3. The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1186/s12964-024-01597-8↗
  4. Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype. Co-author DOI 10.1172/jci.insight.151353↗
  5. Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion. Co-author DOI 10.3390/cells10102520↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Oliver Holger Krämer · 3 shared papers, 2021–2026 · strength 0.59
  2. Alexandra Nguyen · 3 shared papers, 2021–2026 · strength 0.59
  3. Maximilian Reichert · 3 shared papers, 2022–2026 · strength 0.50
  4. Günter Schneider · 3 shared papers, 2021–2026 · strength 0.46
  5. Christian Schneeweis · 2 shared papers, 2022–2026 · strength 0.30
  6. Felix Orben · 2 shared papers, 2022–2026 · strength 0.30
  7. Lukas Krauß · 2 shared papers, 2022–2026 · strength 0.30
  8. Carolin Schneider · 2 shared papers, 2022–2026 · strength 0.30
  9. Roland Michael Schmid · 2 shared papers, 2022–2026 · strength 0.30
  10. Roland Rad · 2 shared papers, 2022–2026 · strength 0.30
  11. Matthias Wirth · 2 shared papers, 2022–2026 · strength 0.30
  12. Dieter Saur · 2 shared papers, 2022–2026 · strength 0.30
  13. Alexander Quaas · 1 shared paper, 2026 · strength 0.20
  14. Moritz Reese · 1 shared paper, 2026 · strength 0.20
  15. Sofya Tishina · 1 shared paper, 2026 · strength 0.20
  16. Anna Trauzold · 1 shared paper, 2026 · strength 0.20
  17. Silvia von Karstedt · 1 shared paper, 2026 · strength 0.20
  18. Igor A. Astsaturov · 1 shared paper, 2026 · strength 0.20
  19. Michael B. Ghadimi · 1 shared paper, 2026 · strength 0.19
  20. Marian Grade · 1 shared paper, 2026 · strength 0.19
  21. Ulrich Bernd Keller · 1 shared paper, 2026 · strength 0.19
  22. Constanza Tapia Contreras · 1 shared paper, 2026 · strength 0.19
  23. Hazal Köse · 1 shared paper, 2026 · strength 0.19
  24. Sebastian Mueller · 1 shared paper, 2026 · strength 0.19
  25. Elisabeth Heßmann · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.